Kilitch Drugs (India) Ltd is a speciality pharmaceutical company engaged in manufacturing and trading of pharmaceutical products in domestic and international markets.
Financial Results:
- Kilitch Drugs (India) Ltd reported Revenues for Q1FY24 of ₹36.56 Crores up from ₹33.45 Crore year on year, a rise of 9.3%.
- Total Expenses for Q1FY24 of ₹32.59 Crores up from ₹31.52 Crores year on year, a rise of 3.39%.
- Consolidated Net Profit of ₹3.06 Crores up 75.86% from ₹1.74 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹2.09, up 60.77% from ₹1.30 in the same quarter of the previous year.